S.E. Karpiak

Tau-targeting therapies for Alzheimer disease: current status and future directions

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

GM1 ganglioside protects nucleus basalis from excitotoxin damage: Reduced cortical cholinergic losses and animal mortality

Selective uptake by Purkinje neurons of antibodies to S-100 protein